Drugmaker Pfizer said on Wednesday that a final analysis of data from its late-stage coronavirus vaccine trial suggests that the vaccine can prevent COVID-19 in people who have not been exposed to the virus before.
Drugmaker Pfizer said on Wednesday that a final analysis of data from its late-stage coronavirus vaccine trial suggests that the vaccine can prevent COVID-19 in people who have not been exposed to the virus before.
